Jinsoo Chung

机构：National Cancer Center · ORCID：0000-0003-2251-5331

发表论文 200 篇 · 总被引 2962 次 · h-index 28

代表论文

• Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2022 · The Lancet Oncology · 被引 296)
• Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study (2024 · Journal of Clinical Oncology · 被引 177)
• Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome (2020 · Journal of Surgical Oncology · 被引 36)
• Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database (2024 · Journal of Korean Medical Science · 被引 29)
• The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy (2020 · Scientific Reports · 被引 24)
• Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (2021 · Frontiers in Oncology · 被引 20)